KEISHA THIGPEN: Open Payments
NPI 1790279875 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 17 payments from 6 companies in 2025. Trend: 2023 $692 · 2024 $714 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $193 |
| Ardelyx, Inc. | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Lilly USA, LLC | 1 | $28 |
| Novo Nordisk Inc | 1 | $17 |
Products named: LINZESS, IBSRELA, RINVOQ, TREMFYA, MAVYRET, ENTYVIO, OMVOH, CREON.
Industry payments across VA — which companies pay providers there.
